Trovan and Injection site oedema - a phase IV clinical study of FDA data
Summary:
Injection site oedema is reported as a side effect among people who take Trovan (trovafloxacin mesylate), especially for people who are female, 60+ old, also take Rocephin,.
The phase IV clinical study analyzes which people have Injection site oedema when taking Trovan. It is created by eHealthMe based on reports of 2,226 people who have side effects when taking Trovan from the FDA, and is updated regularly.
What is Trovan?
Trovan has active ingredients of trovafloxacin mesylate. eHealthMe is studying from 2,227 Trovan users. Check the latest studies of Trovan.
What is Injection site oedema?
Injection site oedema is found to be associated with 259 drugs and 342 conditions by eHealthMe. Check the latest studies of Injection site oedema.
2,226 people reported to have side effects when taking Trovan.
Among them, 11 people (0.49%) have Injection site oedema.

Among these 11 people:
What is the gender of people who have Injection site oedema when taking Trovan? *
- female: 80 %
- male: 20 %
What is the age of people who have Injection site oedema when taking Trovan? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 22.22 %
- 50-59: 0.0 %
- 60+: 77.78 %
What are other drugs people take besides Trovan? *
- Morphine: 2 people, 18.18%
- Rocephin: 2 people, 18.18%
- Zoloft: 1 person, 9.09%
- Demerol: 1 person, 9.09%
- Dilacor Xr: 1 person, 9.09%
- Droperidol: 1 person, 9.09%
- Imdur: 1 person, 9.09%
- Isordil: 1 person, 9.09%
- Lasix: 1 person, 9.09%
- Premarin: 1 person, 9.09%
What are other side effects people have besides Injection site oedema? *
- Injection Site Pain: 4 people, 36.36%
- Injection Site Erythema (redness at injection site): 4 people, 36.36%
- Injection Site Pruritus (severe itching at injection site): 3 people, 27.27%
- Skin Blushing/flushing (a sudden reddening of the face, neck): 2 people, 18.18%
- Application Site Pain: 2 people, 18.18%
- Application Site Oedema: 2 people, 18.18%
- Nausea (feeling of having an urge to vomit): 1 person, 9.09%
- Itching: 1 person, 9.09%
- Injection Site Dermatitis: 1 person, 9.09%
- High Blood Pressure: 1 person, 9.09%
* Approximation only. Some reports may have incomplete information.
Do you take Trovan and have Injection site oedema?
- Check whether Injection site oedema is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Trovan:
- Trovan (2,227 reports)
Injection site oedema treatments and more:
- Injection site oedema (2,648 reports)
How severe was Injection site oedema and when was it recovered:
Expand to all the drugs that have ingredients of trovafloxacin mesylate:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Trovan:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Injection site oedema:
- Injection site oedema (259 drugs)
Browse all the conditions that are associated with Injection site oedema:
- Injection site oedema (342 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on trovafloxacin mesylate (the active ingredients of Trovan) and Trovan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Calcium Gluconate cause Dyspnea? - 23 seconds ago
- Drug interactions of Propranolol Hydrochloride and Finasteride - 27 seconds ago
- Drug interactions of Entecavir and Lenvatinib - 30 seconds ago
- Acromegaly and Parkinson'S Disease - 33 seconds ago
- Could Gleevec cause Hepatotoxicity Aggravated? - 34 seconds ago
- Partial Seizures and Joint Injury - 38 seconds ago
- Drug interactions of Aricept and Tecfidera - 44 seconds ago
- Could Toprol-Xl cause Gastritis? - 46 seconds ago
- Drug interactions of Darvocet and Indomethacin - 46 seconds ago
- Drug interactions of Etodolac and Darvocet-N 100 - 59 seconds ago